İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

TUĞBA BAĞCI ÖNDER

PROFESÖR

KOÇ ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Tıbbi Biyoloji

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 34
  • Proje 0
  • Kitap 0
  • Bildiri 0
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 16 Q2 3 Q3 2 Q4 0
WoS (JCR) Q1 12 Q2 6 Q3 1 Q4 2
TR Index 1 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 1
Ort. yüzdelik 83.1%
Üst %1 payı 0.0%
Üst %10 payı 33.3%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 34 yayın

Scopus (SJR)
Q1 16 Q2 3 Q3 2 Q4 0
WoS (JCR)
Q1 12 Q2 6 Q3 1 Q4 2
TR Index
1 makale

Makale listesi

  1. 2022 Tumor cell infiltration to the brain in glioblastoma: from mechanisms to clinical perspectives Cancers DOI https://www.mdpi.com/2072-6694/14/2/443 YÖKSİS SJR Q1 JCR Q2
  2. 2022 The neutralization effect of Montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies MOLECULAR THERAPY DOI https://linkinghub.elsevier.com/retrieve/pii/S1525-0016(21)00521-9 YÖKSİS SJR Q1 JCR Q1
  3. 2021 Parameters Influencing the Transfection Efficiency of PEGylated Chitosan Nanoparticles: Experimental and Modeling Approach Advanced Nanobiomed Research DOI https://onlinelibrary.wiley.com/doi/full/10.1002/anbr.202100033 YÖKSİS
  4. 2021 IDH mutations in glioma, double edged sword in clinical applications? Biomedicines DOI https://www.mdpi.com/2227-9059/9/7/799 YÖKSİS SJR Q1 JCR Q2
  5. 2021 Glioma-on-a-Chip models Micromachines DOI https://www.mdpi.com/2072-666X/12/5/490 YÖKSİS SJR Q2 JCR Q2
  6. 2021 Epigenetic regulation of apoptosis in cancers Cancers DOI https://www.mdpi.com/2072-6694/13/13/3210 YÖKSİS SJR Q1 JCR Q1
  7. 2021 EPIKOL, a chromatin-focused CRISPR/Cas9 library identifies cancer-specific epigenetic vulnerabilities bioRxiv DOI https://www.biorxiv.org/content/10.1101/2021.05.14.444239v1 YÖKSİS
  8. 2021 Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization ONCOGENE DOI 10.1038/s41388-021-01697-6 YÖKSİS SJR Q1 JCR Q1 OpenAlex 65.5%
  9. 2021 Protein scaffold-based multimerization of soluble ACE2 efficiently blocks SARS-CoV-2 infection in vitro bioRxiv DOI 10.1101/2021.01.04.425128 YÖKSİS
  10. 2021 Combined inhibition of KDM6A/B and HDACs exacerbates integrated stress response and mediates therapeutic effects in IDH1-mutant glioma bioRxiv DOI 10.1101/2020/11/26/400234 YÖKSİS
  11. 2020 Loss of PRC2 or KMT2D-COMPASS Generates Two Quasi-Mesenchymal Cell States with Distinct Metastatic Abilities Nature Cell Biology DOI https://aacrjournals.org/cancerres/article/80/23_Supplement/PR05/645709/Abstract-PR05-Loss-of-PRC2-or-KMT2D-COMPASS YÖKSİS SJR Q1 JCR Q1
  12. 2020 Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma Frontiers in Neuroscience DOI 10.3389/fnins.2020.578316. YÖKSİS
  13. 2020 TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway Neurological Research DOI 10.1080/01616412.2020 YÖKSİS
  14. 2020 The neutralization effect of Montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies bioRxiv DOI 10.1101/2020.12.26.424423 YÖKSİS
  15. 2019 The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme Cell Death Discovery DOI 10.1038/s41420-019-0144-z YÖKSİS SJR Q2 JCR Q2
  16. 2019 Identification of SERPINE1 as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling Cancers DOI 10.3390/cancers11111651 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 95.6%
  17. 2019 The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma Cell Death Disease DOI 10.1038/s41419-019-2107-y YÖKSİS SJR Q1 JCR Q1 OpenAlex 88.2%
  18. 2019 May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents? EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY DOI 10.1016/j.ejmech.2019.04.070 YÖKSİS SJR Q1 JCR Q1
  19. 2019 Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer ONCOGENE DOI 10.1038/s41388-019-1116-8 YÖKSİS SJR Q1 JCR Q1
  20. 2018 Investigation of the effects of histone deacetylase inhibitors (HDACi) on apoptotic pathway in glioblastoma multiforme (GBM) FEBS Open Bio YÖKSİS SJR Q2 JCR Q4

Akademisyenlere dön